-transparent.png){kind=logo}
The incidence of auditory toxicity resulting from therapy with ticarcillin (T) (12 g/sq m/day) in combination with gentamicin (G) (200 mg/sq m/day), amikacin (A) (600 mg/dq m/day), or netilmicin (N) (280 mg/sq m/day) was compared. Before administration of these antibiotic combinations to febrile, granulocytopenic patients, baseline audiograms were determined by a pharmacist using a portable audiometer. The before-therapy audiograms for 32 patients receiving T and G, 29 receiving T and A, and 29 receiving T and N were compared with the audiograms after the completion of therapy. The mean length of therapy was seven days. Two patients (6.2%) receiving T and G, one (3.4%) receiving T and N, and one (3.4%) receiving T and A developed auditory toxicity with bilateral decreases of at least 20 decibels at one or more frequencies. The incidence of auditory toxicity secondary to aminoglycoside exposure was low, and the relative auditory toxicity among the three aminoglycosides appeared to be similar.
J F Bender, and
C L Fortner, and
S C Schimpff, and
W R Grove, and
D M Hahn, and
L J Love, and
P H Wiernik
August 1985,
American journal of ophthalmology,
J F Bender, and
C L Fortner, and
S C Schimpff, and
W R Grove, and
D M Hahn, and
L J Love, and
P H Wiernik
September 1974,
The Journal of antibiotics,
J F Bender, and
C L Fortner, and
S C Schimpff, and
W R Grove, and
D M Hahn, and
L J Love, and
P H Wiernik
July 1977,
Modern veterinary practice,
J F Bender, and
C L Fortner, and
S C Schimpff, and
W R Grove, and
D M Hahn, and
L J Love, and
P H Wiernik
March 1991,
Journal of veterinary pharmacology and therapeutics,
J F Bender, and
C L Fortner, and
S C Schimpff, and
W R Grove, and
D M Hahn, and
L J Love, and
P H Wiernik
January 1980,
Toxicology,
J F Bender, and
C L Fortner, and
S C Schimpff, and
W R Grove, and
D M Hahn, and
L J Love, and
P H Wiernik
January 1971,
Pure and applied chemistry. Chimie pure et appliquee,
J F Bender, and
C L Fortner, and
S C Schimpff, and
W R Grove, and
D M Hahn, and
L J Love, and
P H Wiernik
October 1978,
The Journal of infectious diseases,
J F Bender, and
C L Fortner, and
S C Schimpff, and
W R Grove, and
D M Hahn, and
L J Love, and
P H Wiernik
July 1990,
British journal of clinical pharmacology,
J F Bender, and
C L Fortner, and
S C Schimpff, and
W R Grove, and
D M Hahn, and
L J Love, and
P H Wiernik
December 1982,
Antimicrobial agents and chemotherapy,
J F Bender, and
C L Fortner, and
S C Schimpff, and
W R Grove, and
D M Hahn, and
L J Love, and
P H Wiernik
June 1979,
Antimicrobial agents and chemotherapy,
